![Gaurav Gupta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gaurav Gupta
Direttore/Membro del Consiglio presso NewAmsterdam Pharma BV
Provenienza dei contatti di primo grado di Gaurav Gupta
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gaurav Gupta tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Foley & Lardner LLP
![]() Foley & Lardner LLP Miscellaneous Commercial ServicesCommercial Services Foley & Lardner LLP engages in the provision of legal services. Its practice areas include employee benefits and executive compensation, environmental, estates and trusts, finance, international tax and transfer pricing, private equity and venture capital, real estate, securities, commodities and exchange regulation, taxation, and transactions. The company was founded by Asahel Finch and William Pitt Lynde on September 8, 1842 and is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sonogene LLC | Director/Board Member | ||
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
Omthera Pharmaceuticals, Inc.
![]() Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Zielbio, Inc.
![]() Zielbio, Inc. Medical SpecialtiesHealth Technology Zielbio, Inc. develops a technology for identification of cancerous diseases. Its technology identifies high-value biomarkers of disease as well as companion targeting peptides capable of delivery of therapeutic payloads and as imaging agents. The company was founded by Kimberly A. Kelly, Gregory B. Fralish, Todd William Bauer in 2010 and is headquartered in Charlottesville, VA. | Medical Specialties | Director/Board Member | |
MATINAS BIOPHARMA HOLDINGS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder | |
Iowa State University | College/University | Doctorate Degree | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Corporate Officer/Principal | |
University of Amsterdam | College/University | Corporate Officer/Principal | |
Morningside Group Ltd.
![]() Morningside Group Ltd. Investment ManagersFinance Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong. | Investment Managers | Consultant / Advisor | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Symphony Genisis, Inc.
![]() Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Pharmaceuticals: Major | Director/Board Member | |
Cerenis Therapeutics, Inc.
![]() Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | ||
International Atherosclerosis Society
![]() International Atherosclerosis Society Miscellaneous Commercial ServicesCommercial Services The International Atherosclerosis Society is based in Houston, TX. The private company's focus and description are not provided in the given dictionary. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Atherosclerosis Society | Corporate Officer/Principal | ||
Abcentra, Inc.
![]() Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
GreenLight Biosciences, Inc.
![]() GreenLight Biosciences, Inc. BiotechnologyHealth Technology GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA. | Biotechnology | Director/Board Member | |
Novartis Venture Funds (USA)
![]() Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor | |
Harvard Business School | College/University | Masters Business Admin | |
Rutgers Business School | College/University | Masters Business Admin | |
Inotrem SA
![]() Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
The University of Iowa College of Law | College/University | Graduate Degree | |
Dutch Atherosclerosis Society | Director/Board Member | ||
KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
Shionogi USA Holdings, Inc. | Corporate Officer/Principal | ||
Corvidia Therapeutics, Inc.
![]() Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Apic Bio, Inc.
![]() Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA. | Packaged Software | Director/Board Member | |
Allysta Pharmaceuticals, Inc.
![]() Allysta Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Allysta Pharmaceuticals, Inc. operates as a biopharmaceutical company. The frim develops medicine for ophthalmology, particularly dry eye disease and glaucoma. The company was founded by Henry H. Hsu and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Alentis Therapeutics AG
![]() Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Prilenia Therapeutics BV
![]() Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member | |
NewAmsterdam Pharma Holding BV
![]() NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Director/Board Member Director/Board Member | |
Jocasta Neuroscience, Inc.
![]() Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Jocasta Neuroscience, Inc. provides biological products development services. The company is based in New Castle, DE. | Biotechnology | Director/Board Member | |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
NanoPhoria Srl
![]() NanoPhoria Srl Drugstore ChainsRetail Trade NanoPhoria Srl is an Italian company that operates as a non-viral drug delivery platform. The company is based in Milan, Italy. The company was founded by Daniele Catalucci, Michele Iafisco, Alessio Alogna, Claudio de Luca. Claudio de Luca has been the CEO since incorporation. | Drugstore Chains | Director/Board Member | |
Trofi Nutritionals, Inc.
![]() Trofi Nutritionals, Inc. Specialty StoresRetail Trade Trofi Nutritionals, Inc. is a private company located in the US that is focused on advancing personal health management through next-generation nutritional wellness solutions. The American company works with partners to translate functional compound discoveries into nutritional solutions. | Specialty Stores | Founder | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
SonoThera, Inc.
![]() SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 34 |
Paesi Bassi | 8 |
Svizzera | 4 |
Canada | 2 |
Hong Kong | 2 |
Settori
Health Technology | 22 |
Consumer Services | 10 |
Commercial Services | 8 |
Finance | 5 |
Retail Trade | 3 |
Posizioni
Director/Board Member | 69 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 14 |
Founder | 14 |
Chief Tech/Sci/R&D Officer | 9 |
Contatti più connessi
Insiders | |
---|---|
Louis Lange | 35 |
Michael Davidson | 27 |
Jason Robert Dinges | 22 |
Douglas Kling | 12 |
Patrick Michael Round | 11 |
Juliette Audet | 11 |
Johannes J. P. Kastelein | 10 |
Sander van Slootweg | 2 |
- Borsa valori
- Insiders
- Gaurav Gupta
- Connessioni Società